IngentaConnect Risk factors for fibrosis progression in HIVHCV coinfected patien...

Authors: Schiavini, M¹; Angeli, E¹; Mainini, A¹; Zerbi, P²; Duca, PG³; Gubertini, G¹; Vago, L²; Fociani, P²; Giorgi, R¹; Cargnel, A¹

Source: HIV Medicine, Volume 7, Number 5, July 2006 , pp. 331-337(7)

Publisher: Blackwell Publishing

Abstract:

Objectives

To identify predictive factors for moderate/severe liver fibrosis and to analyse fibrosis progression in paired liver biopsies from HIV-positive patients with chronic hepatitis C virus (HCV) infection. Methods

HIV/HCV coinfected patients followed at the 2nd Department of Infectious Diseases of L. Sacco Hospital in Milan, Italy, with at least one liver biopsy specimen were retrospectively evaluated. Results

A total of 110 patients were enrolled in the study. In a univariate analysis, predictive factors of Ishak–Knodell stage ≥3 were a history of alcohol abuse [odds ratio (OR) 3.6, P=0.004], alanine aminotransferase level >100 IU/L at biopsy (OR 2.4, P=0.05), necro-inflammatory grade ≥9 (OR 37.14, P<0.0001) and CD4 count <350 cells/μL at nadir (OR 5.3, P=0.05). In a multivariate analysis, age >35 years (OR 3.19, P=0.04) and alcohol abuse (OR 4.36, P=0.002) remained independently associated with Ishak–Knodell stage. Paired liver biopsies were available in 36 patients; 18 showed an increase of at least one stage in the subsequent liver biopsy. Either in a univariate or in a multivariate analysis, a decrease of CD4 cell count of more than 10% between two biopsies (OR 6.85, P=0.002) was significantly associated with liver fibrosis progression. Conclusion

Our findings highlight the relevance of encouraging a withdrawal of alcohol consumption in people with chronic HCV infection and of carrying out close follow-up of patients, especially if they are more than 35 years old. It is therefore mandatory to evaluate HIV/HCV coinfected patients for anti-HCV treatment and to increase CD4 cell count through antiretroviral therapy in order to reduce the risk of fibrosis progression and to slow the evolution of liver disease.

Keywords: HCV; HIV; liver fibrosis

Document Type: Research article

DOI: 10.1111/j.1468-1293.2006.00384.x

Affiliations: 1: 2nd Department of Infectious Diseases, Sacco Hospital, Milan, 2: Department of Pathology, Sacco Hospital, Milan University, Milan, and 3: Medical Statistics Unit, Preclinical Sciences Department, Milan University, Milan, Italy

You have access to the full text article on a website external to Ingentaconnect.

Please click here to view this article on InterScience.

You may be required to register and activate access on InterScience before you can obtain the full text. If you have any queries please contact onlinehelp@oxon.blackwellpublishing.com

Risk factors for fibrosis progression in HIV/HCV coinfected patients from a retrospective analysis of liver biopsies in 1985–2002